Compounds and compositions as kinase inhibitors
US8546370B2 · kind B2 · utility
7Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 2009 |
| Grant date | Oct 1, 2013 |
| Priority date | — |
| Expiry date | Jan 20, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a novel class of 2,7-naphthyridin derivatives; pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly Syk, ZAP70, KDR, FMS, FLT3, c-Kit, RET, TrkA, TrkB, TrkC-GR-1R, Alk, c-FMS, or combinations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.